BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND TRIM27, DASS-46L4_6, RFP, 5987, ENSG00000234495, RNF76 AND Staging
1465 results:

  • 1. Addition of Contrast-enhanced Mammography to Tomosynthesis for breast cancer Detection in Women with a Personal History of breast cancer: Prospective TOCEM Trial Interim Analysis.
    Berg WA; Berg JM; Bandos AI; Vargo A; Chough DM; Lu AH; Ganott MA; Kelly AE; Nair BE; Hartman JY; Waheed U; Hakim CM; Harnist KS; Reginella RF; Shinde DD; Carlin BA; Cohen CS; Wallace LP; Sumkin JH; Zuley ML
    Radiology; 2024 Apr; 311(1):e231991. PubMed ID: 38687218
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Determining the Need for Metastatic staging in Patients with Bilateral breast cancers.
    Alcantara VS; Chan SMZ; Wong FY; Allen JC; Lim GH
    Curr Oncol; 2024 Apr; 31(4):1936-1946. PubMed ID: 38668048
    [No Abstract]    [Full Text] [Related]  

  • 3. Alternative Lymphatic Drainage Pathways in the Trunk Following Oncologic Therapy.
    Mehta M; Sarrami S; Moroni E; Fishman J; De La Cruz C
    Ann Plast Surg; 2024 Apr; 92(4S Suppl 2):S258-S261. PubMed ID: 38556685
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. CEM immediately after contrast-enhanced CT: a one-step staging of breast cancer.
    Ancona A; Telegrafo M; Fella RR; Iamele D; Cantore S; Moschetta M
    Eur Radiol Exp; 2024 Apr; 8(1):32. PubMed ID: 38556593
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Locoregional staging of breast cancer: contrast-enhanced mammography versus breast magnetic resonance imaging.
    Terzoni A; Basile P; Gambaro AC; Attanasio S; Rampi AM; Brambilla M; Carriero A
    Radiol Med; 2024 Apr; 129(4):558-565. PubMed ID: 38512618
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Integrating PANoptosis insights to enhance breast cancer prognosis and therapeutic decision-making.
    Wang S; Li Z; Hou J; Li X; Ni Q; Wang T
    Front Immunol; 2024; 15():1359204. PubMed ID: 38504988
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clipping a Positive Lymph Node Improves Accuracy of Nodal staging After Neoadjuvant Chemotherapy for breast cancer Patients, but Does It Drive Management Changes?
    Costarelli L; Arienzo F; Broglia L; La Pinta M; Scavina P; Meli EZ; Colavito MH; Ascarelli A; Campagna D; Mastropietro T; Manna E; Amato M; Andrulli AD; Schiavone A; Minelli M; Fortunato L
    Ann Surg Oncol; 2024 May; 31(5):3186-3193. PubMed ID: 38427160
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Clinical characteristics and prognostic factors of breast cancer patients with tumor deposits in the ipsilateral axillary region].
    Xiao JJ; Huang ML; Yan CJ; Ling R; Wei HL
    Zhonghua Zhong Liu Za Zhi; 2024 Feb; 46(2):146-154. PubMed ID: 38418189
    [No Abstract]    [Full Text] [Related]  

  • 9. Anatomy Versus Biology: What Guides Chemotherapy Decisions in Older Patients With breast cancer?
    Record SM; Thomas SM; Tian WM; van den Bruele AB; Chiba A; DiLalla G; DiNome ML; Kimmick G; Rosenberger LH; Woriax HE; Hwang ES; Plichta JK
    J Surg Res; 2024 Apr; 296():654-664. PubMed ID: 38359680
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. breast cancer Sentinel Lymph Node Detection Rate: First Large Scale Multi-Centric Data for Technetium Phytate.
    Omranipour R; Abassi M; Nazarian N; Gholami B; Heydari S; Eslami B; Abdollahi A; Alipour S
    Arch Iran Med; 2023 Nov; 26(11):618-622. PubMed ID: 38310421
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [A Case of Malignant Lymphoma of the Bile Duct Mimicking Cholangiocarcinoma].
    Saeki S; Tokumitsu Y; Shindo Y; Matsui H; Nakajima M; Kimura Y; Iida M; Suzuki N; Takeda S; Ioka T; Nagano H
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1627-1629. PubMed ID: 38303363
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A pancancer analysis of the clinical and genomic characteristics of multiple primary cancers.
    Zhang B; He L; Zhou C; Cheng X; Li Q; Tang Y; Li F; Huang T; Tu S
    Sci Rep; 2024 Jan; 14(1):2367. PubMed ID: 38287125
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. BRCA1 methylation in breast duct carcinoma, a practical study in Duhok-Iraq.
    Hasan NA; Pity IS
    Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):34-39. PubMed ID: 38279496
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Evaluation of blood supply and metabolism in tumor, axillary lymph node and normal breast tissue with F-18 FDG PET/CT in breast cancer: comparison with pathological prognostic factors.
    Abdulrezzak U; Akgun H; Tutus A; Kula M; Dogan S; Oz AB; Ok E
    BMC Womens Health; 2024 Jan; 24(1):45. PubMed ID: 38229093
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Polo-like kinase 1 as a biomarker predicts the prognosis and immunotherapy of breast invasive carcinoma patients.
    Shen J; Zhang W; Jin Q; Gong F; Zhang H; Xu H; Li J; Yao H; Jiang X; Yang Y; Hong L; Mei J; Song Y; Zhou S
    Oncol Res; 2023; 32(2):339-351. PubMed ID: 38186570
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Reliability of predicting low-burden (≤ 2) positive axillary lymph nodes indicating sentinel lymph node biopsy in primary operable breast cancer - a retrospective comparative study with PET/CT and breast MRI.
    Sae-Lim C; Wu WP; Chang MC; Lai HW; Chen ST; Chou CT; Liao CY; Huang HI; Chen ST; Chen DR; Hung CL
    World J Surg Oncol; 2024 Jan; 22(1):12. PubMed ID: 38183069
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Prediction of therapy response of breast cancer patients with machine learning based on clinical data and imaging data derived from breast [
    Jannusch K; Dietzel F; Bruckmann NM; Morawitz J; Boschheidgen M; Minko P; Bittner AK; Mohrmann S; Quick HH; Herrmann K; Umutlu L; Antoch G; Rubbert C; Kirchner J; Caspers J
    Eur J Nucl Med Mol Imaging; 2024 Apr; 51(5):1451-1461. PubMed ID: 38133687
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The use of axillary ultrasound (AUS) to assess the nodal status after neoadjuvant chemotherapy (NACT) in primary breast cancer patients.
    Leinert E; Lukac S; Schwentner L; Coenen A; Fink V; Veselinovic K; Dayan D; Janni W; Friedl TWP
    Surg Oncol; 2024 Feb; 52():102016. PubMed ID: 38056112
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Critical assessment of resource waste in staging and follow-up of breast cancer.
    Bonometto JVB; Sette CVM; Santi PX; Maselli-Schoueri JH; Giglio AD; Cubero DIG
    Rev Assoc Med Bras (1992); 2023; 69(12):e20230565. PubMed ID: 38055451
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. breast cancer survival after mammography dissemination in Brazil: a population-based analysis of 2,715 cases.
    Fernandes JO; Machado BF; Cardoso-Filho C; Nativio J; Cabello C; Vale DB
    BMC Womens Health; 2023 Dec; 23(1):644. PubMed ID: 38049765
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 74.